ITGAM and neoplasm: In contrast, CD11b+Gr1+ cells isolated from sensitive tumors were unable to mediate refractoriness to anti-VEGF treatment, indicating that the tumor directly modulates CD11b+Gr1+ cells to promote angiogenesis independent of VEGF.